Volume 2, Problème 3 (2005)
Article de révision
New advances in interleukin 1 blockade for the treatment of rheumatoid arthritis
Joseph A Markenson
Article de révision
Interferon alpha therapy and Type 1 diabetes in patients with hepatitis C: pathophysiologic insights
Ayse Aytaman, Gul Bahtiyar and Samy I McFarlane
Article de révision
Therapy of chronic renal insufficiency – from renal physiology to cardiovascular outcomes
Rainer U Pliquett
article de recherche
PTH-related protein and Type 1 parathyroid hormone receptor mRNA expression in rat ventricular myocardial hypertrophy
Antony Halapas, Peter Lembessis, Antigone Sourla, Costas Pantos, Dennis V Cokkinos and Michael Koutsilieris
article de recherche
Preparation of a polymeric reservoir naltrexone delivery device: Effect of PEG content of the PLA membrane on drug release
Rassoul Dinarvand, Shadi H Moghadam, Pantea Sayar, Mahsa Alaee and Fatemeh Atyabi
article de recherche
Does the addition of lamotrigine to risperidone improve psychotic symptoms and cognitive impairements in chronic schizophrenia?
Shahin Akhondzadeh, K Mackinejad, SA Ahmadi-Abhari and ZM Alem
article de recherche
Influence of serum epidermal growth factor on mechanical ventilation and survival in patients with acute respiratory distress syndrome
Pooneh Salari, Mojtaba Mojtahedzadeh and Mohammad Abdollahi
Cour de rapport
Chronic tendon pain: no tendinitis, but high levels of glutamate and a vasculoneural ingrowth – implications for a new treatment?
Hakan Alfredson and Lars Ohberg
Article de révision
Are the benefits of NSAIDs to decrease the risk of Alzheimer\'s disease a MIRAGE?
John B Standridge
Évaluation des médicaments
Management of community-acquired lower respiratory tract infections: gemifloxacin; a new economic paradigm
Gary Patou, Glenn Tillotson and Joseph Blondeau
